OptimizeRx Corp. (OPRX) — Financial statements
Income statement, balance sheet, and cash flow for OptimizeRx Corp. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 109↑18.8% | 92↑28.8% | 72↑14.5% | 62↑1.9% | 61 | |
| Cost of Revenue | 40↑22.6% | 33↑14.4% | 29↑21.9% | 23↓8.5% | 26 | |
| Gross Profit | 69↑16.7% | 59↑38.4% | 43↑10.1% | 39↑9.3% | 36 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 50↓18.0% | 61↑5.6% | 58↑17.8% | 49↑78.9% | 28 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 6 | |
| SG&A Expenses | 50↓18.0% | 61↑5.6% | 58↑17.8% | 49↑48.3% | 33 | |
| Other Expenses | 7↓41.1% | 12↑4.8% | 11↑458.0% | 2↓3.1% | 2 | |
| Operating Expenses | 57↓21.7% | 73↑5.5% | 69↑35.2% | 51↑45.3% | 35 | |
| Total Costs & Expenses | 97↓8.0% | 106↑8.1% | 98↑31.0% | 75↑22.7% | 61 | |
| Operating Results | ||||||
| Operating Income | 12↑188.0% | -14↑48.1% | -26↓114.8% | -12↓3503.7% | 0.36 | |
| Depreciation & Amortization | 4↓0.0% | 4↑80.2% | 2↑18.8% | 2↑2.9% | 2 | |
| EBITDA | 16↑284.2% | -9↑58.3% | -21↓126.3% | -9↓504.8% | 2 | |
| EBIT | 12↑191.2% | -13↑44.2% | -24↓107.3% | -11↓3267.7% | 0.36 | |
| Interest & Other Income | ||||||
| Net Interest Income | -5↑15.3% | -6↓890.1% | 0.74↓13.4% | 0.85↑4919.7% | 0.02 | |
| Interest Income | 0.35↑7.3% | 0.33↓85.0% | 2↑157.2% | 0.85↑4919.7% | 0.02 | |
| Interest Expense | 5↓14.1% | 6↑323.7% | 1 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -0.48↑82.1% | -3↓215.9% | -0.85 | 0.00 | |
| Other Income / Expenses | -5↑10.0% | -6↓558.7% | 1↑45.3% | 0.85↑4919.7% | 0.02 | |
| Income Before Tax | 7↑135.9% | -19↑23.0% | -25↓120.0% | -11↓3125.4% | 0.38 | |
| Income Tax Expense | 2↑150.8% | 0.73↑109.5% | -8 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 5↑125.5% | -20↓14.5% | -18↓53.6% | -11↓3125.4% | 0.38 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 5↑125.5% | -20↓14.5% | -18↓53.6% | -11↓3125.4% | 0.38 | |
| Bottom-Line Net Income | 5↑125.5% | -20↓14.5% | -18↓53.6% | -11↓3125.4% | 0.38 | |
| EPS (Basic) | 0.28↑125.5% | -1.10↓6.8% | -1.03↓60.9% | -0.64↓3022.4% | 0.02 | |
| EPS (Diluted) | 0.27↑124.5% | -1.10↓6.8% | -1.03↓60.9% | -0.64↓3090.7% | 0.02 | |
| Weighted Average Shares | 19↑1.4% | 18↑6.8% | 17↓3.7% | 18↑3.2% | 17 | |
| Weighted Average Diluted Shares | 19↑3.9% | 18↑6.8% | 17↓3.7% | 18↑0.5% | 18 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.